Potential therapeutic effect of turmeric contents against SARS-CoV-2 compared with experimental COVID-19 therapies: in silico study

Recent discovery and development of inhibitors targeting coronaviruses

(2020) Thanigaimalai Pillaiyar et al.   DRUG DISCOVERY TODAY

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

(2020) Roujian Lu et al.   LANCET

Anti-HCV, nucleotide inhibitors, repurposing against COVID-19

(2020) Abdo A. Elfiky   LIFE SCIENCES

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

(2020) Daniel Wrapp et al.   SCIENCE

Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion

(2020) Shuai Xia et al.   CELL RESEARCH

Déjà vu: Stimulating open drug discovery for SARS-CoV-2

(2020) Sean Ekins et al.   DRUG DISCOVERY TODAY

Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19

(2020) Nisha Muralidharan et al.   JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS

Fast Identification of Possible Drug Treatment of Coronavirus Disease-19 (COVID-19) through Computational Drug Repurposing Study

(2020) Junmei Wang   Journal of Chemical Information and Modeling

COVID-19 spike-host cell receptor GRP78 binding site prediction

(2020) Ibrahim M. Ibrahim et al.   JOURNAL OF INFECTION

The potential chemical structure of anti‐SARS‐CoV‐2 RNA‐dependent RNA polymerase

(2020) Jrhau Lung et al.   JOURNAL OF MEDICAL VIROLOGY

Rapid Identification of Potential Inhibitors of SARS‐CoV‐2 Main Protease by Deep Docking of 1.3 Billion Compounds

(2020) Anh-Tien Ton et al.   Molecular Informatics

Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors

(2020) Zhenming Jin et al.   NATURE

Structure of the RNA-dependent RNA polymerase from COVID-19 virus

(2020) Yan Gao et al.   SCIENCE

A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV

(2020) Meng Yuan et al.   SCIENCE

Repurposing antimalarials and other drugs for COVID-19

(2020) Patricia Schlagenhauf et al.   Travel Medicine and Infectious Disease

Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases

(2020) Cynthia Liu et al.   ACS Central Science

Identification of potential Mycolyltransferase Ag85C inhibitors of Mycobacterium tuberculosis H37Rv via Virtual High Throughput Screening and Binding free energy studies

(2020) Ragini Pant et al.   JOURNAL OF MOLECULAR GRAPHICS & MODELLING

Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study

(2020) Abdo A. Elfiky   LIFE SCIENCES

In silico studies on therapeutic agents for COVID-19: Drug repurposing approach

(2020) Bhumi Shah et al.   LIFE SCIENCES

Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease

(2020) Mahmoud Kandeel et al.   LIFE SCIENCES

Curcumin is an APE1 redox inhibitor and exhibits an antiviral activity against KSHV replication and pathogenesis

(2019) He Li et al.   ANTIVIRAL RESEARCH

Synthesis of novel Azol-β-lactam derivatives starting from phenyl piperazine and investigation of their antiurease activity and antioxidant capacity comparing with their molecular docking studies

(2019) Arif Mermer et al.   JOURNAL OF MOLECULAR STRUCTURE

Synthesis and Molecular Docking Studies of Novel Triazole Derivatives as Antioxidant Agents

(2019) Musa Özil et al.   LETTERS IN ORGANIC CHEMISTRY

Antiviral potential of curcumin

(2018) Dony Mathew et al.   Journal of Functional Foods

Synthesis, in vitro urease inhibition and molecular docking studies of some novel quinazolin-4(3H)-one derivatives containing triazole, thiadiazole and thiosemicarbazide functionalities

(2018) Emre Menteşe et al.   BIOORGANIC CHEMISTRY

OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins

(2015) Edward Harder et al.   Journal of Chemical Theory and Computation

Curcumin and its analogues: a potential natural compound against HIV infection and AIDS

(2015) Sahdeo Prasad et al.   Food & Function

A Review on Antibacterial, Antiviral, and Antifungal Activity of Curcumin

(2014) Soheil Zorofchian Moghadamtousi et al.   Biomed Research International

Inhibition of Enveloped Viruses Infectivity by Curcumin

(2013) Tzu-Yen Chen et al.   PLoS One

An in silico evaluation of the ADMET profile of the StreptomeDB database

(2013) Fidele Ntie-Kang   SpringerPlus

Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials

(2012) Subash C. Gupta et al.   AAPS Journal

Curcumin inhibits HCV replication by induction of heme oxygenase-1 and suppression of AKT

(2012) MING-HO CHEN et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Curcumin Inhibits Rift Valley Fever Virus Replication in Human Cells

(2012) Aarthi Narayanan et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Sesquiterpenes from the rhizome of Curcuma longa with inhibitory activity on superoxide generation and elastase release by neutrophils

(2009) Jih-Jung Chen et al.   FOOD CHEMISTRY

Curcumin inhibits influenza virus infection and haemagglutination activity

(2009) Da-Yuan Chen et al.   FOOD CHEMISTRY

Diaryl derivatives from the root tuber of Curcuma longa

(2008) Li-Yao Wang et al.   BIOCHEMICAL SYSTEMATICS AND ECOLOGY

Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer

(2008) N. Dhillon et al.   CLINICAL CANCER RESEARCH